Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors

Patent 11993613 was granted and assigned to AbbVie Inc. on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Anthony Mastracchio0

Andrew William Phillips0

Puneet Kumar0

Mark Mills0

Date of Patent

May 28, 2024

0

Patent Application Number

181928100

Date Filed

March 30, 2023

0

Patent Citations

US Patent 8586604 Inhibitors of the microsomal prostaglandin E2 synthase-1

0

US Patent 7560553 Use of fuse nicotinamides to promote neurogenesis

0

US Patent 7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds

0

US Patent 7709471 Compounds

0

US Patent 8377945 Small molecule inhibitors of spleen tyrosine kinase (SYK)

0

US Patent 8466186 Compounds

0

US Patent 10626081 Farnesoid X receptor agonists and uses thereof

0

US Patent 10662195 Protein kinase conjugates and inhibitors

0

...

Patent Primary Examiner

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool